Prostate Cancer Survivor: The Story of John Sands

0
(0)

John Sands is an example of the impact of an early diagnosis of prostate cancer. When he was 61-years-old, he was diagnosed with cancer after his doctor noticed abnormally high prostate-specific antigen (PSA) levels. In this NJTV News video, a specialist in the field also discusses the importance of early diagnosis of prostate cancer, the second most common type of cancer among American men.

Here’s what you need to know about prostate cancer in 5 minutes.

“That was the more comforting part of it: knowing that I caught it early enough,” said John Sands in the video shared by the NJTV News’ Youtube channel. John Sands’ physician explained his options, which included active surveillance, radiation therapy or surgery. “The reason why I chose surgery was to have that piece of mind, not just for me, but for my family.”

“[Prostate cancer] is very common and it is something that most people would never know that they have it unless we find it early,” states Michael Lasser, MD, Medical Director, Robotic Surgery, at the Jersey Shore University Medical Center. “Research is ongoing but we don’t have a great answer to why it is so common and what the specific causes are.”

The physician also emphasizes the importance of early diagnosis and seeking a physician for a PSA test. PSA is a protein produced by cells of the prostate gland, which can be measured via a blood sample. High levels of PSA in the blood might indicate prostate cancer.

However, it’s also important that patients seek a specialist who knows how to interpret the results and ask for further examinations if needed since a PSA abnormal level can indicate different problems of the prostate. In order to avoid alarmism or misunderstandings, patients older than 50, or who are particularly at risk of prostate cancer are advised to seek a health care provider to check their health and, if needed, get a PSA screening.

Lear more about prostate cancer treatment options.

Prostate Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • NCCN and Rubraca
  • Orgovyx and FDA approval
  • Lynparza
  • Erleada results

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *